Overview
Novel central nervous system drug research and development.
Funding
USD estimates from the source recordListed 1 funding record. Latest funding: $50M (A轮), Sep 28, 2026.
Annual trendUnit: USD estimate
| Date | Amount | Investors | Source |
|---|---|---|---|
| Sep 28, 2026 | $50M | Decheng Capital | Source ↗ |
Valuation
USD estimates from the source recordListed 1 valuation record.
Annual trendUnit: USD estimate
No chartable valuation estimates yet.
1 listed record lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Source |
|---|---|---|---|
| Sep 28, 2026 | — | Decheng Capital | Source ↗ |
Revenue
USD estimates from the source recordNo revenue records are listed yet.
Annual trendUnit: USD estimate
No chartable revenue estimates yet.
No revenue rows to list.
Team, products & investors
Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
中枢神经系统创新药研发